Science News

Read how Donald Zack, a past BrightFocus grantee, has been advancing cures for glaucoma and macular degeneration.

A research team, supported in part by BrightFocus Foundation, wanted to know whether patients who received the drug L-DOPA as treatment for Parkinson’s or other diseases were protected from AMD. After combing through massive amounts of medical chart data, their answer is yes.

BrightFocus Foundation applauds the three lifelong researchers who won this year’s Nobel Prize in chemistry, and commends the Nobel committee for its selections.

BrightFocus-funded grantees have shown how a bad form of tau, a protein that is a major player Alzheimer’s disease, may spread throughout the brain.

The World Health Organization (WHO) has called for a major shift in the way society views older persons in its latest report, "World Report on Ageing and Health."

Research by BrightFocus grantee Matthew Campbell, PhD, of Trinity College Dublin, represents a potential new way to help clear the brain of a build-up of the toxic amyloid beta (Aβ) that leads to Alzheimer’s.

Researchers funded by BrightFocus Foundation are bringing us closer to preventing the spread of Alzheimer’s disease in the brain. Learn more about this exciting research.

Seven BrightFocus grantees had their research chosen as a “Hot Topic” by the ARVO Scientific Program Committee. Read about their exciting work.